The present invention relates to the compounds for lowering RhoA genes, pharmaceutical composition and its application method and medicine box comprising the compound. These compounds, composition, method and medicine box in terms of the subject that the disease for having negative consequence with wherein RhoA expression or the related disease of illness or illness and/or symptom are suffered from treatment and for offer neuroprotection in terms of be useful.
